Categorynews

Highs & Lows of Stem Cell Therapies: Off- The-Shelf Solutions for Regenerative Advanced Therapies – ResearchAndMarkets.com

January 14, 2020 Off By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Highs and Lows of Stem Cell Therapies: Off- The-Shelf Solutions” report has been added to ResearchAndMarkets.com’s offering.

The Report Includes:

  • An overview of recent advances in stem cell therapies and coverage of potential stem cells used for regenerative advanced therapies
  • Discussion on role of genomic and epigenomics manipulations in generating safe and effective treatment options
  • Identification of autologous and allogeneic cells and their usage in creating advanced therapy medical products (ATMPs)
  • Information on 3D cell culture and discussion on advances in gene editing and gene programming techniques such as CRIPSR/Cas9, TALEN, and ZINC fingers
  • Insights into commercial and regulatory landscape, and evaluation of challenges and opportunities for developing autologous and allogenic off the shelf solutions

Key Topics Covered:

Chapter 1 Sources and Characteristics of Stem Cells

  • Introduction

Chapter 2 New Technologies Driving Stem Cell Development

  • Advances in Cell Culture
  • Advances in Isolation Technologies
  • Advances in Genome Manipulation

Chapter 3 Safety, Efficacy and Logistical Challenges

  • Toxicity-Related Treatment Issues
  • Logistical Challenges

Chapter 4 Off-the-Shelf Solutions

  • Expanding the Course of Stem Cells
  • More Precise Genomic Manipulation of Cells
  • Reduction in Cell-to-Cell Variation
  • Improved Shelf Life

Chapter 5 Companies and Technologies to Watch

  • Athersys Inc.
  • BrainStorm Cell Therapeutics Inc.
  • Caladrius Biosciences
  • Cellular Biomedicine Group Inc.
  • Fate Therapeutics Inc.
  • Gamida Cell Ltd.
  • International Stem Cell Corporation
  • Orgenesis Inc.
  • Pluristem Therapeutics Inc.
  • Sangamo Therapeutics Inc.
  • TheraCell Inc.
  • ThermoGenesis Holdings
  • Vericel Corporation
  • VistaGen Therapeutics Inc.
  • Zelluna Immunotherapy Inc.
  • Analyst’s Credentials
  • Related Reports

Chapter 6 References

For more information about this report visit https://www.researchandmarkets.com/r/7us8rs

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900